ARNA - Arena Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 51.07B
Enterprise Value 31B
Trailing P/E -36.82
Forward P/E 1-9.99
PEG Ratio (5 yr expected) 10.46
Price/Sales (ttm)9.09
Price/Book (mrq)12.92
Enterprise Value/Revenue 38.52
Enterprise Value/EBITDA 660.00

Financial Highlights

Fiscal Year
Fiscal Year Ends Dec 31, 2016
Most Recent Quarter (mrq)Jun 30, 2017
Profitability
Profit Margin -16.27%
Operating Margin (ttm)7.24%
Management Effectiveness
Return on Assets (ttm)2.62%
Return on Equity (ttm)-42.21%
Income Statement
Revenue (ttm)117.73M
Revenue Per Share (ttm)4.55
Quarterly Revenue Growth (yoy)-31.70%
Gross Profit (ttm)108.63M
EBITDA 16.71M
Net Income Avi to Common (ttm)-19.16M
Diluted EPS (ttm)-0.74
Quarterly Earnings Growth (yoy)N/A
Balance Sheet
Total Cash (mrq)130.76M
Total Cash Per Share (mrq)3.33
Total Debt (mrq)63.58M
Total Debt/Equity (mrq)77.05
Current Ratio (mrq)3.21
Book Value Per Share (mrq)2.11
Cash Flow Statement
Operating Cash Flow (ttm)-70.56M
Levered Free Cash Flow (ttm)12.46M

Trading Information

Stock Price History
Beta 2.25
52-Week Change 371.76%
S&P500 52-Week Change 319.09%
52 Week High 328.28
52 Week Low 311.30
50-Day Moving Average 325.29
200-Day Moving Average 319.24
Share Statistics
Avg Vol (3 month) 3562.19k
Avg Vol (10 day) 3508.87k
Shares Outstanding 539.22M
Float 36.69M
% Held by Insiders 10.26%
% Held by Institutions 149.42%
Shares Short 31.25M
Short Ratio 30.54
Short % of Float 35.08%
Shares Short (prior month) 32.09M
Dividends & Splits
Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21/10
Last Split Date 3Jun 19, 2017